As the government struggles to hire skilled workers to fend off hackers, cyberattacks on federal agencies are up between 50 and 100 percent in the past year.
A new survey by the Professional Services Council found that at least 28 percent of chief information officers at federal agencies reported an increase in cyberattacks of 51 to 100 percent over the past year.
The increasing threat of cyber hacks against the government isn’t surprising. Earlier this year, the Government Accountability Office listed federal IT operations as one of the most serious weaknesses in the federal government and in its annual “High Risk” report, the GAO labeled this vulnerability a major threat to national security.
Just last week, the Obama administration announced that Chinese cyber thieves hacked into the Office of Personnel Management’s massive government data system and accessed more than 4 million federal workers’ personal data. ABC News reported that the hackers potentially gained access to some Cabinet member data as well.
In the aftermath of the breach, President Obama called on agencies to ramp up cyber security efforts. However, the problem, according to the PSC survey, is that the government is having trouble recruiting skilled cyber experts.
Some 63 percent of CIOs reported that their agencies were not sufficiently prepared to develop necessary talent. Most cited limited resources and government salaries as obstacles to competing with employers in the private sector.
Commerce Department CIO Steve Cooper said hiring young people is a major challenge. The average age of Commerce employees is about 50 years old, NextGov noted.
The CIOs’ responses are in line with a separate GAO report from earlier this year that found there is a major skills gap within the federal workforce when it comes to IT and cybersecurity.
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.